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(Communicated by Kunihiko SUZUKI, M.J.A.)
Abstract: Protein quality control (QC) in the endoplasmic reticulum (ER) comprises many
steps, including folding and transport of nascent proteins as well as degradation of misfolded
proteins. Recent studies have revealed that high-mannose-type glycans play a pivotal role in the QC
process. To gain knowledge about the molecular basis of this process with well-deﬁned homogeneous
compounds, we achieved a convergent synthesis of high-mannose-type glycans and their
functionalized derivatives. We focused on analyses of UDP-Glc: glycoprotein glucosyltransferase
(UGGT) and ER Glucosidase II, which play crucial roles in glycoprotein QC; however, their
speciﬁcities remain unclear. In addition, we established an in vitro assay system mimicking the
in vivo condition which is highly crowded because of the presence of various biomacromolecules.
Keywords: protein quality control, high-mannose-type glycans, UDP-Glc: glycoprotein
glucosyltransferase (UGGT), glucosidase II, macromolecular crowding
Introduction
Oligosaccharides or glycan chains are important
constituents of intra- and extracellularly distributing
glycoconjugates such as glycoproteins, glycolipids,
and proteoglycans. Their roles are numerous, and
mostly essential for normal cellular activities. The
most prominent among them are cell development,
immune response,1),2) infection,3),4) and malignant
transformation.5),6) However, all in all, detailed
understanding on molecular basis of their functions
has been limited.
In order to advance the study of biological
roles of glycan chains, chemical synthesis has been
expected to play a pivotal role. Compared to
other classes of biooligomers, such as peptides
(proteins)7),8) and oligonucleotides (DNA and
RNA),9),10) synthesis of glycan chain is less straight-
forward due to several reasons. Firstly, formation
of glycosidic linkages that connect sugar residues
generates two isomers, namely ,- and O-glycosides.
Additionally, biologically interesting glycan chains
often comprise branching structure, instead of being
linear oligomers. By contrast, since peptide and
nucleotide chains are linear and their structures are
solely deﬁned by sequence or alignment of respective
components, synthesis of these oligomers is not
associated with isomer formation.
In order for proteins to function normally,
structural modiﬁcations are often indispensable.
Among numerous types of post- or co-translational
modiﬁcations of proteins, introduction of asparagines
(Asn)-linked (or N-linked) glycan chains is one of the
most prominent. Introduction of N-linked glycans
takes place in the endoplasmic reticulum (ER) of the
cells in a co-translational manner.11),12) This type of
glycans is added to Asn residues embedded in the
“consensus” triad Asn-X-Ser/Thr (Ser: serine, Thr:
threonine, X: any amino acid except proline).13)
Glycan chains are characterized by their steric
bulkiness as well as the presence of a large number
of hydroxyl groups which makes them highly
hydrophilic. Consequently, they are able to give a
signiﬁcant impact to physicochemical properties of
proteins, conferring stability, water solubility, and
resistance to protease cleavage.14)–17)
Glycoconjugates, including N-glycosylated pro-
teins, mostly exist on the cell-surface and play pivotal
roles in intercellular recognition such as signal
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More recent studies have provided convincing evi-
dence on their roles in protein quality control (QC) in
the ER.18)–20) It is a wide-ranging process, including
folding and transport of nascent proteins as well as
degradation of incurably misfolded proteins. In this
context, pivotal roles of N-linked glycans as key
signals in glycoprotein QC have attracted growing
attention. To gain molecular basis of this process,
establishment of reliable in vitro experimental sys-
tems is essential. However, in many cases, complexity
originating from structural heterogeneity of naturally
occurring glycoproteins has been diﬃcult to be
removed and hampered unambiguous interpretation
of experimental results.
Our study summarized in this article has aimed
to reduce aforementioned ambiguity by using chemi-
cally synthesized glycans and their protein conju-
gates, and gain clear understanding of glycan-protein
interplays in the ER.
1. Biosynthesis and processing of N-glycosylated
proteins and their functions in the ER
Modiﬁcation of N-glycosylated proteins occurs
co-translationally in the ER. This reaction is
catalyzed by a multisubunit enzyme, oligosaccharyl-
transferase (OST).11),12) Amazingly, a lipid-linked
oligosaccharide consisting of as many as 14 sugar
residues is transferred en bloc by this enzyme.21),22)
Studies have indicated that oligosaccharides
attached to proteins are key signals in glycoprotein
QC system. It ensures that only glycoproteins that
have attained correct 3D structure are transported to
Golgi apparatus for further processing and eventual
secretion. On the other hand, those that have failed
to achieve proper folding are transported to cytosol
for ubiquitination followed by degradation by 26S
proteasomes.
In most eukaryotes such as mammals, oligo-
saccharide consists of 14 sugar residues of three
D-glucose (Glc), nine D-mannose (Man), and two
N-acetyl-D-glucosamine (GlcNAc) residues (Glc3-
Man9GlcNAc2; G3M9). It is ﬁrstly assembled on a
lipid carrier, dolichylphosphate (Dol-P), by succes-
sive action of glycosyltransferases in the lumen of
the ER. Subsequently, the tetradecasaccharide
G3M9 is transferred by the action of OST, as a
block to Asn residues in the consensus of nascent
polypeptides.
Thus introduced G3M9 is ﬁrstly processed by
glucosidase I (G-I), which removes the outermost Glc
residues to produce diglucosylated tridecasaccharide
(Glc2Man9GlcNAc2; G2M9). The latter in turn is
digested by glucosidase II (G-II), a dual activity
enzyme, which is able to cleave Glc residues linked
to Glc (Glc,1!3Glc) and Man (Glc,1!3Man)
residues and generate dodeca- (Glc1Man9GlcNAc2;
G1M9) and undecasaccharide (Man9GlcNAc2; M9),
successively. The dodecasaccharide G1M9 formed by
the ﬁrst activity of G-II enters the glycoprotein-
speciﬁc folding process, called calnexin/calreticulin
(CNX/CRT) cycle.18),19),23) (Fig. 1)
In this cycle, CNX and CRT function as
chaperones. They also possess a nearly identical
property as lectin, and speciﬁcally bind Glc,1!
3Man containing glycans such as G1M9. Both of
them are proposed to exist as complexes with
ERp57,24),25) a member of peptide disulﬁde isomerase
superfamily. By virtue of their lectin activity, these
chaperons are able to capture G1M9 containing
glycoproteins and facilitate their folding. Subsequent
trimming by G-II completely removes the Glc
residue, leading guest glycoproteins into the non-
glucosylated glycoform M9, which will be liberated
from CNX/CRT.
Intriguingly, there is a proof-reading system in
the CNX/CRT cycle, which is conducted by UDP-
Glc: glycoprotein glucosyltransferase (UGGT). This
enzyme functions as a “folding sensor” in the ER.
Namely, only when protein folding is incomplete,
glycoproteins processed to M9 are re-glucosylated
to G1M9 by UGGT. By regenerating G1M9, this
enzyme enables repeated interaction of glycoproteins
with CNX/CRT and maximizes their folding. Sub-
strate recognizing mode of UGGT is highly subtle. In
addition to glycan structures, it discriminates folding
state of protein backbones.26)–28) Previous study29)
has shown that its reactivity toward glycopeptides
clearly correlates with the proportion of hydrophobic
amino acids, suggesting that exposed hydrophobic
patch of misfolded protein is the key element in
UGGT recognition.
As for glycan speciﬁcity, our study clariﬁed that
M9 was the most reactive, while depletion of Man
residue resulted in marked reduction of reactivity. T
of Man8GlcNAc2 (M8) and Man7GlcNAc2 (M7) being
ca. 1/2 and 1/5 of G9, respectively (vide infra).
An isoform of UGGT (HUGT2) has been
identiﬁed in human.30),31) HUGT2 shares 55% iden-
tity with human UGGT (HUGT1). HUGT2 and
HUGT1 mRNA are broadly expressed ubiquitously
in every tissue. However, no glucose transfer activity
has been identiﬁed for this protein and, consequently,
its physiological role has yet to be identiﬁed.
Y. ITO and Y. TAKEDA [Vol. 88, 32UGGT is a widely conserved protein. Studies
with mouse embryonic stem cells have shown that its
deﬁciency is lethal in most cases.32) On the other
hand, it has been shown to be an activation factor of
BiP (GRP78), a molecular chaperone in the ER, and
overexpression of UGGT was reported to enhance the
expression level of medicinally important recombi-
nant proteins including erythropoietin and interferon
..33) Glycoproteins that have not achieved correct
folding are slowly processed by ER mannosidase I,
and partially demannosylated glycoproteins are
transported to cytosol for degradation, while a
possibility that they are partially rescued by BiP
has been put forward, suggesting that an intricate
fail-safe mechanism is provided in the quality control
system.34)
2. Functional analysis of glycoprotein glycans
using chemically synthesized probes
2.1. Synthesis of ER-related high-mannose-
type glycans. Despite the wealth of information
provided by recent studies, ﬁne picture of glycopro-
tein QC has been unclear. Because most of previous
studies have employed substrates derived from
naturally occurring glycoproteins, results have been
complicated by heterogeneity of glycans.
Primary aim of our study was to systematically
synthesize N-linked glycans, which were expected to
be powerful in removing such diﬃculty.
However, fully chemical synthesis of biologically
relevant glycans consisting of more than ten sugar
residues is not a trivial task. Among several problems
associated with stereochemical control, certain type
of so-called 1,2-cis glycosides such as O-linked
mannose (O-Man) are diﬃcult to construct selec-
tively.35) Our study established a strategy which
realized completely selective and eﬃcient synthesis of
O-Man glycosides, by using a concept dubbed “intra-
molecular aglycon delivery” (IAD).36) (Fig. 2A) Our
approach employed a p-methoxybenzyl (PMB) group
introduced to 2-position of mannose. Under oxidative
conditions, the PMB group was converted to mixed
acetal-type tethered intermediate, from which ex-
clusive formation of 1,2-cis glycoside was realized in
high yield (>80%).37) More recent studies have shown
that eﬃciency as well as generality of the IAD was
further enhanced by using 2-naphthylmethyl (NAP)
group in place of PMB.38)
Fig. 1. (A) N-glycan processing in ER. (B) Glycoprotein folding and quality control machineries in the ER.
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cans was achieved in a convergent manner. (Fig. 2B)
Combination of fragments corresponding to core
trisaccharide (ManGlcNAc2; A), trimannose (Man3;
B), branched mannose (Man5-3; C1,2,3,4) and
glucose (Glc3-1; D1,2,3) components allowed us to
prepare all possible high-mannose-type glycans.39)
Furthermore, standardized protocol to functionalize
these glycans with a variety of aglycons has been
established. For instance, our study was directed to
modiﬁcation of glycans with methotrexate (MTX),
which turned out to be highly versatile. Namely,
MTX conjugated glycans (CHO-MTX) were easily
detectable because of intense UV absorbance of
MTX. In addition, they can be easily grafted to
dihydrofolate reductase (DHFR), providing glyco-
protein mimetic (CHO-MTX-DHFR), by virtue
of a strong aﬃnity between MTX and DHFR.40)
(Fig. 3)
2.2. Analysis of UGGT, a folding sensor in
the ER. As was discussed in Chapter 1, UGGT
recognizes glycoproteins that have not achieved
correct folding as substrates and incorporates Glc
residue to the terminal Man of the A-arm. As a
matter of fact, denatured thyroglobulin (Tg) has
been employed as a benchmark substrate of this
enzyme, while native Tg is a poor substrate.41),42)
However, precise speciﬁcity of UGGT has been
unclear. Fortuitously, our experiments revealed that
UGGT smoothly glucosylates MTX-modiﬁed glycan
(CHO-MTX; CHOFM9), which became a well-
deﬁned non-peptidic synthetic substrate of UGGT.43)
(Fig. 4A)
Subsequently, speciﬁcity of UGGT in terms of
glycan structure was revealed to be M9>M8>M7.
Intriguingly, although the reactivity of M7-MTX was
low, its aﬃnity to UGGT was the highest (Km),
indicating that UGGT strongly recognizes the inner
region of high-mannose-type glycans. In support of
this notion, a glycan lacking the innermost GlcNAc
was completely devoid of activity. (Fig. 4B)
Further study has shown that other types of
glycan modiﬁcation with ﬂuorescently active sub-
stituents, such as BODIPY, or Fmoc, a widely used
amino protecting group, were fruitful providing high
reactivity substrates of UGGT.44) In particular,
BODIPY modiﬁed glycans were preferable to high-
sensitivity detection of the enzymatic activity,
because of their high reactivity and strongly ﬂuo-
rescent activity of BODIPY.
Fig. 2. Systematic synthesis of high-mannose-type oligosaccharide. (A) Stereoselective construction of O-mannoside linkage with
intramolecular aglycon delivery (IAD). (B) Convergent synthesis of high-mannose-type oligosaccharide.
Y. ITO and Y. TAKEDA [Vol. 88, 34A common feature of misfolded proteins is
speculated to be the presence of hydrophobic patch
exposed on their surface, which is likely to be an
element recognized by UGGT. This speculation has
been supported by several lines of evidence, such as
1) unmodiﬁed glycans are poorly glucosylated by
UGGT, 2) M9 containing n-propyl, a modestly
hydrophobic aglycon, was marginally reactive, and
3) the reactivity of M9-MTX was markedly attenu-
ated when it was conjugated with DHFR. (Fig. 4A)
2.3. Analysis of glucosidase II (G-II). G-II
successively cleaves Glc,1-3Glc (cleavage-1) and
Glc,1-3Man (cleavage-2) linkages. (Fig. 1A) In order
to evaluate the magnitude of these activities, we
Fig. 3. Synthetic N-glycan molecular probes by introducing various aglycons. The term “CHO” means carbohydrate. MTX bind tightly
with DHFR to form glycan-attached proteins (CHO-MTX-DHFR).
Fig. 4. Analysis of UGGT. (A) UGGT activity against protein substrate and synthetic M9-derivatives. (B) Glycan speciﬁcity analysis of
UGGT and kinetics of CHO-MTX.
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analysis unambiguously conﬁrmed that the cleavage-
1 is by far faster than the cleavage-2.45) In addition,
the observation that the cleavage-2 was strongly
suppressed by the addition of CRT provided an
implication that glycoproteins enter the CNX/CRT
cycle immediately after they are converted to G1M9
by cleavage-1 of G-II.
In the ER, combined action of UGGT and G-II
(cleavage-2) interconverts M9 and G1M9 glycoforms.
Simultaneously, trimming by mannosidase(s) occurs,
giving G0 and G1 glycans that have less than 9 Man
residues. Studies in 1980s concluded that G-II cleaves
G1M9 exceedingly faster than other monoglucosy-
lated glycoforms.21),46),47) However, our study using
structurally deﬁned substrates (CHO-MTX; CHO F
G1M9-7) revealed that the diﬀerence of reactivity
was not as large as has been believed. Most notice-
ably, the reactivity of G1M8B-MTX which lacks a
Man residue of the B-arm, was nearly identical with
G1M9-MTX, while reaction rate of its regioisomer
(G1M8C-MTX) was reduced to ca. 50%. (Fig. 5A)
Interestingly, when conjugated to DHFR, the activ-
ity of G1M8B was markedly higher than G1M9.
These results implicate that the speciﬁcity of G-II is
sensitive to nature of aglycon, and possibly, to folding
state of proteins.
Furthermore, inhibition experiments using sev-
eral glycans indicated that G-II strongly recognizes
the terminal Man of the C-arm. Among M9, M8(B),
M8(C) and M7, inhibitory activity of M7 was the
strongest.48) Since, in the ER, misfolded glycopro-
teins may be major targets of mannosidase(s), it
would be tempting to speculate that accumulation of
demannosylated glycoforms would suppress the G-II
activity and decelerate the entry of newly generated
glycoproteins into CNX/CRT. (Fig. 5B)
Interestingly, non-natural dodecasaccharides
that had D-galactose, D-glucuronic acid, or 3-, 4-, 6-
deoxy-D-glucose residue in place of Glc were all
smoothly converted to M9.49) Taken together, G-II,
while stringently recognizing mannose residues of
Fig. 5. Substrate speciﬁcity of G-II. (A) G-II (cleavage-2) activity against various glycoprobes having diﬀerent oligosaccharide or
aglycone structure. (B) Inhibitory activity of various glycoprobes toward Glc trimming from G2M9. (C) Cleavage of various G1M9
analogues by G-II. Gal, Galactose; GlcA, Glucuronic acid; G3d, 3-Deoxyglucose; G4d, 4-Deoxyglucose; G6d, 6-Deoxyglucose.
Y. ITO and Y. TAKEDA [Vol. 88, 36the B- and C-arms, is quite tolerant to structure
perturbation of departing sugar residues. (Fig. 5C)
G-II is a heterodimeric protein, consisting of
,-a n dO-subunit. While the ,-subunit comprises a
catalytic domain, precise function of the other
subunit has been obscure.50) To clarify the issue, we
prepared strains of Aspergillus oryzae in which either
,-o rO-subunit was disrupted, and G-II activity of
their microsomal fraction was tested, by using G2M9-
and G1M9-MTX. Our analysis showed 1) not only
the ,-subunit disruptant, but the O-subunit disrup-
tant was inactive toward all of these glycans,
although the former (but not the latter) was fully
active toward a small molecule substrate pNP-Glc,
and 2) mixed microsomal fractions of both disruptans
exhibited the activity to digest both G2M9 and
G1M9.51) Together, these results provide a clear
indication that the presence of the O-subunit is
essential in order for G-II to exhibit hydrolytic
activity in the ER, possibly by virtue of its ability
to recognize high-mannose-type glycans. (Fig. 6)
2.4. Macromolecular crowding conditions
as pseudo-intracellular environments. While
in vitro biochemical assays are typically performed
in dilute buﬀer solutions containing less than 1% of
proteins, intracellular environments are known to be
highly congested. They consist of various macro-
molecules whose total concentration may reach 30–
40%, creating “macromolecular crowding” condi-
tions.52) Under such conditions, diﬀusion of bulky
molecules such as proteins will be retarded, while
their association may be enhanced and proteins tend
to have more compact conformation. These consid-
erations raise the possibility that intracellular behav-
ior of proteins may not be estimated directly from
conventional in vitro experiments. Accordingly, we
became interested in re-investigating ER related
glycan processing reactions under crowded condi-
tions.53) Interestingly, we observed that the cleavage-
2 of G-II was dramatically enhanced in high
concentrations of bovine serum albumin (BSA),
while the cleavage-1 was not aﬀected. Similar eﬀects
were observed in the presence of other macro-
molecules such as polyethylene glycol or RNase A.
On the other hand, the eﬀect of macromolecular
crowding on glucosylation by UGGT was negligible,
and trimming by ,-mannosidase was markedly
retarded.
Although biological relevance of the eﬀects
exerted by macromolecular crowding must be ad-
dressed carefully, these results implicate that kinetics
as well as speciﬁcities of glycoprotein processing
enzymes may be quite diﬀerent between intracellular
and dilute buﬀer conditions. Previous studies have
lead researchers to believe that the cleavage-1 of G-II
trimming is overwhelmingly faster than the cleavage-
2. However, the observation that the cleavage-2, but
not cleavage-1, of G-II trimming was accelerated
under macromolecular crowding conditions suggests
that, in the ER, diﬀerence of velocities between them
may be much smaller. In fact, recent study that
analyzed in vivo trimming of glycoproteins in S.
cerevisiae supports this prediction.
3. Conclusion
In glycobiology, researches have been challenged
by the diﬃculty in obtaining well-deﬁned homoge-
neous compounds, especially due to microhetero-
geneity of glycoprotein glycans. Furthermore, the
glycoprotein quality control system discriminates
guest proteins according to their folding state in
addition to their glycoforms. In spite of quite
extensive studies conducted using substrates of
biological origin, more precise and quantitative
studies, particularly in terms of speciﬁcity to
discriminate subtly diﬀerent glycans, have been
limited. Our study stemmed from systematic syn-
thesis of high-mannose-type glycans proven to be
powerful in revealing speciﬁcities of key players in
glycoprotein quality control such as CRT, UGGT,
and G-II.
The research ﬁled called “chemical biology” aims
to clarify various biological events by exploitating
chemical means, such as organic synthesis. Obvi-
ously, glycobiolgy is not an exception. Because of
glycoconjugate glycans’ structural complexity and
diversity, it will provide exciting research opportu-
nities for synthetic chemists. We predict the impor-
tance of organic synthesis will be more ﬁrmly
established in this area.
Fig. 6. G-II activity toward G2M9-MTX using the membranous
fraction of gene disruptants lacking either the G-II ,-subunit or
O-subunit. The membranous fraction lacking the O-subunit was
inactive against high mannose-type oligosaccharide.
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